HIV-2 EU—supporting standardized HIV-2 drug resistance interpretation : an update

Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.

Palavras-chave

HIV-2 drug-resistance rules Internet tool update

URI

http://hdl.handle.net/10400.26/63057

Citação

Charlotte Charpentier, Dirk Berzow, Quentin Le Hingrat, Rolf Kaiser, Perpetua Gomes, Ana Claudia Miranda, Florence Damond, Jade Ghosn, Jeroen J A van Kampen, Björn-Erik Ole Jensen, Michael Böhm, Annemarie M J Wensing, Diane Descamps, Martin Obermeier, HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update, Clinical Infectious Diseases, Volume 81, Issue 3, 15 September 2025, Pages 539–542, https://doi.org/10.1093/cid/ciaf110

Editora

Oxford University Press

DOI

10.1093/cid/ciaf110

Coleções

EM - Artigos Científicos

Licença CC

Sem licença CC

Métricas Alternativas

Ver registo completo